Dr. Sengsayadeth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-343-7602
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013- Vanderbilt University Medical CenterResidency, Internal Medicine, 2006 - 2009
East Tennessee State University James H. Quillen College of MedicineClass of 2006
Certifications & Licensure
TN State Medical License 2008 - 2026
AL State Medical License 2020 - 2020- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 85 citationsHematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow TransplantationNina Shah, Natalie S. Callander, Siddhartha Ganguly, Zartash Gul, Mehdi Hamadani
Biology of Blood and Marrow Transplantation. 2015-07-01 - 71 citationsOverview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice.Salyka Sengsayadeth, Bipin N Savani, Olalekan Oluwole, Bhagirathbhai Dholaria
Ejhaem. 2022-01-01 - 43 citationsDoes FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Res...Abhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, Hai-Lin Wang, Mahmoud Aljurf
Cancer. 2016-10-01
Press Mentions
Three-Drug Regimen Improves Protection Against GVHD After Stem Cell TransplantJuly 18th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
